Daniele Maggioni

Title: Daniele Maggioni: Innovator in Pharmaceutical Combinations

Introduction

Daniele Maggioni is a notable inventor based in Barzio, Italy. He has made significant contributions to the field of pharmaceuticals, particularly in the treatment of tumors. His innovative work has led to the development of a unique pharmaceutical combination that holds promise for cancer therapy.

Latest Patents

Daniele Maggioni holds a patent for a pharmaceutical combination of an EP4 antagonist and immune checkpoint inhibitors for the treatment of tumors. The invention provides a pharmaceutical combination comprising the EP4 antagonist of Formula (R)-4-(1-(6-(4-(trifluoromethyl)benzyl)-6-azaspiro[2.5]octane-5-carboxamido)cyclopropyl)-benzoic acid or a pharmaceutically acceptable salt thereof, along with at least one immune checkpoint inhibitor. Additionally, a polymorphic form A of sodium salt of the EP4 antagonist is characterized by a specific powder XRD spectrum, which is also described for use in tumor treatment.

Career Highlights

Daniele Maggioni is currently associated with Rottapharm Biotech S.r.l., where he continues to advance his research and development efforts in pharmaceuticals. His work is pivotal in exploring new therapeutic avenues for cancer treatment.

Collaborations

Daniele has collaborated with notable colleagues such as Lucio C Rovati and Antonio Giordani, contributing to the collective expertise in their field.

Conclusion

Daniele Maggioni's innovative contributions to pharmaceutical combinations demonstrate his commitment to advancing cancer treatment. His patent reflects a significant step forward in the fight against tumors, showcasing the potential of combining EP4 antagonists with immune checkpoint inhibitors.